Innovative Flomark IV Bags Enhance Precision in Managing Hospital Patient Fluid Balance
Discover how the Flomark device is revolutionizing inpatient fluid management with precise, easy-to-read flow monitoring, improving safety and outcomes in hospitals.
In hospitals worldwide, maintaining an accurate balance of fluid intake and output for patients is vital to prevent complications such as dehydration or fluid overload. Traditionally, measuring IV fluid flow relies on counting drips, a method prone to human error and variability. Addressing this critical need, Imperial College London researchers, led by industrial designer Jonathan West and surgeon James Kinross, have developed the Flomark—a revolutionary sterile, single-use flow meter designed to seamlessly integrate with standard gravity IV setups.
The Flomark device features a simple yet effective visual indicator comprising a floating ball and a graduated scale displaying milliliters per hour. This innovative tool provides healthcare professionals with an instant, reliable visual cue of fluid flow rates, significantly reducing the risk of measurement inaccuracies. This advancement is especially crucial given that current technology only estimates flow rates and is often error-prone.
This technological breakthrough has garnered substantial investment, securing £300,000 to support the product’s commercial launch and distribution. Inspired by the need for better fluid management tools, the Flomark aims to improve patient safety and clinical outcomes. James Kinross emphasizes that precise fluid management is essential to avoid serious issues like hypovolemia or pulmonary edema, and the new device offers clinicians enhanced control and response to patient needs.
Building upon this innovation, the company received an Innovate UK Smart Grant in 2024 to develop a prototype electronic regulator. This device tracks the float’s position within the flow meter, providing real-time, accurate control of flow rates by adjusting for pressure and resistance changes. CEO Jonathan West envisions a future where combined data from flow meters and urine output monitors will deliver comprehensive real-time fluid management, further safeguarding patient health and easing staff workload.
The development of the Flomark signifies a significant leap towards safer, more precise fluid therapy in hospitals, reducing complications and enhancing patient care quality. It underscores the importance of technological innovation in clinical settings, aligning engineering solutions with vital healthcare needs.
(Source: https://medicalxpress.com/news/2025-06-flomark-iv-bags-accurately-inpatient.html)
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Promising Oral Medication Improves Heart and Muscle Symptoms in Barth Syndrome
A new oral drug, MA-5, shows promising results in improving heart and muscle symptoms in Barth syndrome by targeting mitochondrial dysfunction. This breakthrough could lead to disease-modifying treatment options.
Public Health Success in Dialysis Infection Control Demonstrated by Response Data
Research demonstrates that standard infection control measures effectively prevent Candida auris transmission in dialysis facilities, ensuring patient safety without specialized protocols.
Metabolism's Role in Breastfeeding’s Protective Effect Against Breast Cancer
Emerging research reveals that a woman’s metabolism, particularly mitochondrial function, influences how breastfeeding can reduce breast cancer risk. Personalized nutritional strategies may enhance protective effects and improve prevention efforts.
Breakthrough in Immune System Research: Proteins That Trigger Cellular Immunity in Bone Marrow
Scientists have identified key proteins, Tcf1 and Lef1, that are crucial for initiating T cell development in the bone marrow, advancing our understanding of cellular immunity and opening new avenues for immunotherapy and vaccine development.